Basel Medical Group Ltd (BMGL) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access BMGL Annual Balance Sheets →
By examining balance sheet figures across successive periods, users can identify shifts in Basel Medical Group Ltd's financial structure and capital allocation.
Quarterly Report, GAAP in USD millions
ITEM
(Jun 30 2025)
0 0 0 (Jun 30 2024)
Assets
Cash And Cash Equivalents2.34
Other Short-term Investments0.00
Cash & Short-term Investments2.00
Trade & Other Current Receivables (IFRS combined total)-
Inventories0.30
Other Current Assets7.68
Total Current Assets10.31
Equipment/Property/Plant Net0.22
Deferred Tax Assets0.22
Other Assets, Noncurrent2.50
Total Assets13.25
Liabilities
Accounts Payable0.00
Short-term Debt1.02
Other Liabilities, Current0.00
Total Current Liabilities1.02
Total Long-term Debt0.00
Accrued Income Taxes, Noncurrent0.00
Other liabilities, Noncurrent9.43
Total Liabilities9.43
Stockholders' Equity
Other Equity3.83
Common Stockholder's Equity3.83
Total Stockholder's Equity3.82
Liabilities & Stockholder's Equity13.25
4 historic quarters locked

Sign in to unlock the full Basel Medical Group Ltd balance sheet history.

About Basel Medical Group Ltd Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 20-F filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 20-F (Period: 20250630)
  • Filed with the SEC: November 17, 2025
  • Source: form20-f.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001493152-25-023940

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API License